For tissues to grow and function properly, cells must coordinate actions such as proliferation, differentiation and apoptosis. This coordination is achieved in part by the activation of intracellular signaling pathways that trigger the expression of context-specific target genes.
Introduction
In mammals, relatively few intracellular pathways integrate information from a huge range of sources, including neighboring cells and the physical environment. The resulting activity of signaling pathways can have many consequences, but chief among these is the induction of target genes that constitute a cell's decision to proliferate, differentiate, or adopt an altered functional state. Efforts to systematically map signaling responses have revealed that a single external stimulus often activates many intracellular pathways, and that each pathway's activity state can vary dynamically over time (1) (2) (3) (4) . These observations suggest that cells might use both combinatorial strategies (e.g., gene expression triggered only in response to pathways A and B) and dynamic strategies (e.g., gene expression triggered by sustained activity in pathway A) to connect the cell's overall signaling state to particular responses. Indeed, a growing number of cell fates are thought to be selectively triggered by certain signaling dynamics, thereby functioning as analog filters (Figure 1A) (5) (6) (7) , whereas others may act as digital logic gates by responding only to certain pathway combinations ( Figure 1B) (8) . Yet our understanding of how combinatorial and dynamic decoding are achieved is still limited.
A central challenge is that the relationship between signaling and target gene activation is complex, with multiple regulatory links acting at different steps along the central dogma, an architecture we will call "multi-step regulation." One canonical example of multi-step regulation is found in FOS gene induction by the Ras/Erk pathway. Erk signaling first triggers transcription of fos mRNA; then, within 30-60 min, fos mRNA is degraded through the Erk-induced expression of Zfp36; and finally, the Fos protein is stabilized by Erk phosphorylation (9) (10) (11) (12) .
Together, these interactions are thought to form a circuit that selectively responds only when the duration of Erk activity is above a threshold (Figure 1C) . Multi-step regulation can also provide combinatorial control when sequential steps in gene expression are gated by distinct signaling pathways. For instance, in T cells, engagement of the T cell receptor (TCR) leads to il-2 transcription, but maximal IL-2 secretion requires CD28-dependent signaling acting at posttranscriptional steps that are still poorly defined (Figure 1D) , resulting in AND-gate logic where both TCR and CD28 engagement are required for a strong cytokine response (13) . In both cases, the complexity of multiple nested regulatory links has made it challenging to define the essential set of interactions implement a specific filtering or gating function. A more complete understanding of multi-step regulation would also enable the design of synthetic decoding modules: gene circuits that selectively respond to novel stimulus combinations or dynamics. In such cases, the signal-decoding circuitry may be thought of as a dynamic filter. (B) Target gene induction may also depend on the combination of pathways that are activated, such that signal decoding may be thought of as implementing a logic gate. (c) The induction of Fos protein is a canonical example of dynamic decoding, where sustained but not transient pulse of Erk results in protein accumulation. Erk-mediated regulation of FOS transcription, fos mRNA stability and Fos protein stability is thought to mediate this response. (D) IL-2 induction by T cell stimulation and co-stimulation is thought to occur via combinatorial control. Neither TCR nor CD28 alone are sufficient for protein output but the two together allow for accumulation of IL-2 protein through a poorly-characterized response circuit.
Motivated by these challenges, we set out to establish a general framework for constructing synthetic, signaling-responsive target genes that can be used to implement user-defined, multistep regulatory interactions. We focused specifically on creating and characterizing synthetic immediate-early genes (SynIEGs), a class of fast-responding genes that are induced by a variety of stimuli including the Ras/Erk signaling pathway. We found that SynIEGs faithfully recapitulate the dynamics of immediate-early gene induction: SynIEG transcription kinetics closely match their endogenous counterparts, and a FOS-based SynIEG exhibits dynamic filtering of Erk signaling inputs. We also use the SynIEG platform to define additional regulatory links, revealing an essential role for the BTG2 3' UTR and the micro-RNA miR-21 in suppressing Btg2 protein translation. Finally, we use regulatory elements from the FOS and BTG2 genomic loci to engineer a SynIEG with a novel decoding function: an AND gate that selectively responds only to the combination of growth factor and DNA damage stimuli. Synthetic signaling-responsive target genes thus enable a quantitative, systems-level understanding of the interface between signaling pathways and gene expression, opening the door to engineering novel pathway decoders for controlling complex cell fates.
Results

Developing a synIEG platform for monitoring synthetic target gene induction
Our strategy for constructing synthetic target genes relied on meeting two complementary goals. First, a SynIEG must be able to easily implement different forms of regulation at the mRNA or protein level. Each SynIEG thus combines a signaling-responsive promoter, 5' and 3' mRNA regulatory sequences, and protein-coding sequences into a vector that can be targeted for genomic integration (Figure 2A) . Second, a quantitative understanding of signal decoding requires the ability to monitor mRNA-and protein-level responses over time in each individual SynIEG-expressing cell. Building off of a strategy we recently developed for endogenous target genes (14) , we included a YFP-24xMS2 tag in each SynIEG. In this system, instantaneous transcription can be visualized as a bright nuclear spot when the nascent MS2 RNA loops are bound to the fluorescent RNA-binding protein MCP-mCherry, and protein accumulation can be monitored by YFP fluorescence. As a first test case, we combined a 2-kb region upstream of the FOS transcriptional start site that contains its promoter and canonical upstream regulatory elements (15, 16) , the FOS 5'UTR, the coding sequence for monomeric super-folder YFP (msfYFP), 24xMS2 RNA stem-loops, and the TUBA1B 3'UTR in a single lentiviral vector, which we named fos-tubulin for its 5' and 3' elements, respectively ( Figure 2B) , and introduced it into a clonal NIH3T3 cell line already expressing MCP-mCherry and H2B-iRFP as a nuclear marker (the "chassis" cell line; see Methods) (14) .
We first tested whether expression of the fos-tubulin synthetic immediate-early gene (SynIEG) could be induced by signaling stimuli after either lentiviral transduction or transient transfection, but found that neither strategy was promising. Transient transfection with a fostubulin plasmid drove YFP expression even in the absence of IEG-activating stimuli such as serum ( Figure S1A-B) . Conversely, cells transduced with a fos-tubulin lentiviral vector failed to induce YFP expression even after serum stimulation (Figure S1C ). Based on prior reports that lentiviral targeting constructs can be silenced (17) , we reasoned that treatment with the histone deacetylase inhibitor trichostatin A (TSA) might restore serum responsiveness to a lentiviral fostubulin cell line. Indeed, cells pre-treated with TSA for 12 h exhibited an increase in YFP fluorescence upon serum stimulation, whereas cells treated with either TSA or serum alone showed no change in YFP levels (Figure S1C-D). While these data indicate that lentiviraltransduced SynIEGs can be reactivated from a silent state, the large-scale chromatin remodeling caused by TSA treatment made this an undesirable strategy for implementing SynIEGs.
As an alternative method of synthetic gene delivery, we tested integration using the PiggyBAC transposase, which randomly inserts DNA sequences flanked by ~300-bp targeting sequences into the host genome (18) . We co-transfected "chassis" NIH3T3 cells with plasmids encoding the PiggyBAC transposase enzyme and the fos-tubulin SynIEG flanked by PiggyBAC transposable elements, and sorted clonal cell lines that stably integrated the SynIEG (Figure 2B) .
We observed that fos-tubulin cells stimulated with serum exhibited bright MCP-labeled transcriptional foci and increased YFP fluorescence over time, consistent with an Erk-stimulated IEG response (Figure 2B, Figure S1E-F) . In contrast to lentiviral transduction, silencing was not observed and cells maintained serum-responsiveness even months after cell line generation.
These results confirm that PiggyBAC transposase-based delivery enables the stable integration of complex, signaling-responsive synthetic target genes for interrogating mRNA-and proteinlevel responses.
How well do SynIEGs recapitulate the dynamics of endogenous immediate-early gene activation? To address this question we monitored transcription at individual genomic loci using the MS2/MCP system built into each SynIEG. In this system, the transcription rate of each genomic integration site can be tracked over time based on the intensity of individual fluorescent MCP foci in the nucleus. We generated a clonal cell line harboring multiple integrations of a fos-btg2 SynIEG (containing the FOS 5' regulatory sequence and BTG2 3' UTR), based on our prior work demonstrating that BTG2's long 3' UTR produces exceptionally bright transcriptional foci (14) . Upon serum stimulation, fos-btg2 cells exhibited multiple bright transcriptional foci, each corresponding to transcription from distinct PiggyBAC integration sites ( Figure 2C) . Focus intensity reached a maximum intensity roughly 30 minutes after stimulation and then adapted back to baseline within 90 minutes (Movie S1; Figure 2D ). Transcriptional kinetics were strikingly similar between distinct foci within the same cell, as well as between cells in the same cell line (Movie S1; Figure 2D ).
We next set out to compare the kinetics of serum-stimulated SynIEG transcription with their endogenous IEG counterparts. We had previously established derivatives of the "chassis" NIH3T3 cell line where MS2 stem-loops were integrated at the endogenous FOS and BTG2 loci, providing an ideal testbed for comparison (14) . We stimulated fos-btg2 SynIEG cells and these endogenously-tagged FOS and BTG2 cell lines with 10% serum (Figure S2A) 
SynIEGs elucidate dynamic and combinatorial decoding by FOS and BTG2
We next tested whether SynIEGs could be used to define the regulatory steps that enable target genes to selectively respond to certain combinations or dynamics of upstream signaling.
We focused on the FOS and BTG2 genes, two immediate-early genes that exhibit distinct profiles of signaling-dependent protein expression. FOS is a canonical example of dynamic decoding as it is highly induced by sustained, but not transient, activation of the Ras/MAPK Figure 3A) (11, 12) . In contrast, BTG2 induction appears to depend on the specific stimulus received: Btg2 protein accumulates to high levels upon DNA damage but not growth factor stimulation, even though btg2 mRNA is strongly induced in both cases (14) . We thus set out to construct variants of FOS and BTG2-based SynIEGs to recapitulate and further define their regulatory architecture.
Dynamic decoding of FOS is thought to depend on two forms of post-transcriptional regulation -Erk-dependent destabilization of the FOS 3' UTR (19) and stabilization of Fos protein (11) -although additional forms of regulation have not been ruled out. We thus tested whether this minimal set of regulatory elements would indeed be capable of dynamic filtering.
We combined the FOS promoter, FOS 3'UTR, and a well-characterized Erk-responsive degron from the FOS family member Fra1 (20) to build a SynIEG termed fos-Fra1 deg -fos (Figure 3B) .
The fos-tubulin SynIEG was used as a control lacking both forms of post-transcriptional regulation. We introduced both SynIEGs into "chassis" NIH3T3 cells that were also sorted to express a blue light sensitive OptoSOS system (iLID-OptoSOS) (16, 17) , enabling us to precisely control the dynamics of Ras/Erk pathway activity by varying the duration of illumination (Figure S3A) . In the absence of blue light, SSPB-SOScat is cytosolic and inactive, whereas blue light stimulation induces SSPB-SOScat membrane localization (Figure S3B ) and activates Ras/Erk signaling (Figure S3C-E) .
We incubated OptoSOS-SynIEG cells in serum-free media for 6 h, applied either a 30 min pulse of light ('transient') or continuous illumination ('sustained'), and monitored YFP induction over time (Figure 3C-D) . For fos-tubulin cells, both light stimuli triggered similar increases in YFP fluorescence over time (Figure 3C) , likely because both sustained and transient Erkactivating stimuli cause an identical, 30 min pulse of transcription (Figure 2) (14) . However, we found that in the fos-Fra1 deg -fos clonal cell line, sustained light drove higher protein accumulation than a 20 min light pulse (Figure 3D) . It is important to note that stimulation led to a relatively low overall change in SynIEG protein expression: 40% in the case of fos-tubulin and 20% in the case of fos-Fra1 deg -fos cells over a 3 h timecourse (Figure 3C-D) . This observation is likely to arise from a high residual pool of stable YFP protein that is retained from continuous growth conditions prior to the start of the experiment, a hypothesis we further tested in Figure 4 below. Nevertheless, the observation of dynamic selectivity allows us to conclude that the two post-transcriptional regulatory connections contained in the fos-Fra1 deg -fos SynIEG (Erkdependent protein stabilization and mRNA degradation) are sufficient to confer dynamic selectivity for sustained Erk stimuli.
We next turned our attention to BTG2, whose regulation by various upstream signals is still poorly understood (21) . BTG2 is transcriptionally induced by many cellular inputs, including DNA damage (22, 23) , growth factor signaling (14) , and stress signaling (24) . Strikingly, we previously saw that Btg2 protein levels were unchanged after growth factor stimulation despite strong transcriptional induction (Figure 3E) (14) . Our first goal was to determine whether the block to protein accumulation occurred at the mRNA level (e.g. by regulating mRNA degradation or blocking translation) or at the protein level (e.g. by regulating protein degradation). To determine whether mRNA-level regulation is sufficient, we first constructed a series of SynIEG variants that lacked any Btg2 protein sequence but harbored various combinations of BTG2 and FOS UTR sequences (termed the btg2-btg2, btg2-fos, fos-btg2, and fos-fos SynIEGs). We derived clonal cell lines for each SynIEG, starved each for 4-6 hours, and then stimulated with serum to monitor YFP induction, using identically-treated fos-tubulin SynIEG cells as controls (Figure S4) . We found that all SynIEGs containing the BTG2 3' UTR failed to accumulate YFP in response to serum stimulation (Figure 3F-G) , whereas all other SynIEGs exhibited similar levels of YFP accumulation. Together, these data demonstrate that RNA-level regulation is sufficient to explain Btg2's paradoxical response of high serum-induced expression with no protein accumulation, and implicates regulation contained within the BTG2 3'
UTR.
Prior reports indicate that over a dozen microRNAs may bind to the BTG2 3' UTR and regulate btg2 mRNA stability or protein expression in various cell types and cancers (25) (26) (27) (28) (29) . We focused on miR-21 as a candidate regulator because it is upregulated after growth factor stimulation (in contrast to the majority of microRNAs) (30) , and because miR-21 has been implicated in Btg2 regulation in other contexts (27, 28) . To test whether miR-21 is responsible for Btg2's translational repression after acute growth factor stimulation, we generated cell lines that overexpress miR-21 or an antisense "sponge" to titrate away endogenous miR-21, reasoning that these constructs should have opposite effects on YFP accumulation. We created lentiviral expression vectors containing the U6 promoter driving either miR-21 or the anti-sense sponge, followed by a constitutive CMV promoter driving the expression of TagBFP-NLS to label cells that were successfully transduced. We found that SynIEG cells transduced with the miR-21 sponge exhibited YFP induction after serum stimulation, whereas mock-transduced or miR-21transduced cells failed to accumulate YFP accumulation (Figure 3H) . Together, these data confirm a model whereby growth factor signaling drives BTG2 transcription but miR-21 blocks Btg2 translation from this mRNA. More broadly, our data suggests that SynIEGs provide a flexible system for studying the decoding of cell signaling stimuli at multiple steps along the central dogma, from transcriptional induction (e.g., transcriptional kinetics via MS2/MCP imaging) to translational regulation (e.g., testing different 5' and 3' regulatory sequences) to protein-level regulation (e.g., Erk-dependent stabilization of the Fra1 degron).
A novel AND-gate SynIEG responds to the combination of mitogens and DNA damage
In addition to dissecting the regulation of natural immediate-early genes, SynIEGs are also well-suited for engineering signaling-responsive circuits with novel, desired response functions.
To explore this possibility, we set out to develop a SynIEG which implements a signalingresponse function that has not been previously described for any immediate-early gene: an AND gate in which growth factor stimulation and a second stimulus, DNA damage, are both corequired to induce gene expression.
We took advantage of FOS and BTG2 regulatory elements whose functions could be composed to produce this AND-gate logic. We previously observed that the FOS gene is transcribed in response to growth factor stimulation, regardless of whether DNA damage is present (14) (Figure 4A) . In contrast, 3' UTR-based translational repression of the BTG2 gene is abolished in cells exposed to DNA damage either delivered alone or in combination with serum (14) (Figure 4A) . We reasoned that combining these two regulatory elements could result in a circuit that co-requires both serum and DNA damage to promote transcription and relieve translational repression, respectively (Figure 4B) . We constructed an AND-gate SynIEG with the FOS promoter, FOS 5' UTR, BTG2 3' UTR, and a coding sequence driving expression of a destabilized GFP (dGFP) variant that was chosen to achieve a more potent decrease upon the switch to serum-free media and increase the fold-change in GFP induction after stimulation (Figure 4C) . A constitutive CMV promoter driving TagBFP expression was placed on the same genetic construct to enable fluorescence-based selection of PiggyBAC-transduced NIH3T3 cells. We then performed single-cell sorting to derive two independent clonal cell lines expressing the fos-dGFP-btg2 SynIEG.
We characterized mRNA-and protein-level responses from cells expressing the AND-gate SynIEG in response to three classes of stimuli: doxorubin (DNA damage alone), 1% serum (growth factor alone), or doxorubicin + 1% serum (DNA damage AND growth factor). At the transcriptional level, we observed pronounced MCP foci in fos-btg2 SynIEG-expressing cells when treated with serum regardless of whether doxorubicin was present (Figure 4D) , a result that was consistent with our prior observations from the FOS endogenous locus (14) . At the protein level, neither doxorubicin nor serum alone was able to induce dGFP accumulation, whereas their combination triggered dGFP accumulation (Figure 4E; Figure 5SA) . We further verified that the overall change in dGFP fluorescence (area under the curve; AUC) was significantly increased only by the combination of serum and doxorubicin in both independentlyderived clonal cell lines (Figure 4F; Figure S5B ) and that a control SynIEG (fos-fos) did not exhibit AND-gate logic (Figure S5C) . Taken together, these data demonstrate the successful construction of a stimulus-responsive AND gate using immediate-early gene components.
Expression of a desired genetic payload is enabled only when growth factor stimulation induces SynIEG transcription and DNA damage relieves microRNA-mediated translational repression.
We emphasize that this AND-gate logic has not been reported for any existing endogenous immediate-early gene, indicating that the SynIEG platform can be used to engineer novel signalresponse functions in addition to dissecting endogenous IEG regulation.
Discussion
There is still a critical gap in our understanding of mammalian signal decoding: how target genes interpret complex combinatorial and dynamic inputs from upstream signaling pathways (4).
To address this gap, we set out to build mammalian gene cassettes that allow one to simultaneously monitor the transcription and translation of a gene while modulating its various components (i.e. degrons, UTRs, promoter etc.) (Figure 2A) . After optimizing gene delivery, we quantitatively characterized SynIEG transcription to ensure that their transcriptional regulation was similar to endogenous IEGs (Figure 2C-D, Figure S2 , Movie S1). We then used SynIEGs to recapitulate the response of the FOS gene to dynamic Ras/Erk stimuli (Figure 3A-D) and to dissect how BTG2 responds selectively to DNA damage but not growth factor stimulation despite similar transcriptional behavior in each case (Figure 3E-H) . In both cases, our experiments highlight regulatory links between signaling pathways and downstream target gene expression that act on multiple nodes of the central dogma (e.g., induction of BTG2 transcription but translational inhibition caused by the BTG2 3'UTR), requiring the ability to monitor cellular responses at both transcriptional and post-transcriptional steps. Future studies using SynIEGs can enable the characterization of the signaling pathway to gene expression interface and will shed light on how cells interpret complex biochemical cues to induce a variety of cell fates.
Based on these results, we conjectured that immediate-early genes might also serve as a useful engineering substrate for constructing mammalian cell signaling decoders with desired, novel stimulus-response relationships. Indeed, we found that by combining elements from known immediate-early genes -the FOS serum-responsive promoter and the BTG2 DNA damage-responsive 3'UTR -it was possible to construct a synthetic AND gate that only triggers a 4-fold increase in protein levels in response to combined serum stimulation and DNA damage (Figure 4) . A striking feature of this AND gate is its simple construction from only two elements, a promoter and 3' UTR from two separate endogenous IEGs, without additional fine-tuning or optimization. This simplicity follows from the fact that both elements are regulated at distinct steps of the central dogma. SynIEG protein accumulation occurs only if transcription is activated (via growth factor stimulation) and translation is de-repressed (via DNA damage and micro-RNA regulation). In contrast, engineering AND-gate logic at a single step (e.g. engineering two transcription factors to be mutually required for transcription) often requires complex engineering of three-body interactions (two protein domains with one another and a DNA sequence) (31) . In addition to constructing logic gates, multi-step regulation is likely to be essential for selectively responding to specific signaling dynamics. For instance, feed-forward loops acting on different timescales have been shown to play crucial roles in discriminating sustained from transient stimuli (9, 32) .
We propose that SynIEGs implementing novel decoding functions should find utility as reporters of complex endogenous signaling conditions (e.g. marking cells in which some Pathway 1 and Pathway 2 are both active), or as circuits to control the function of engineered cells (33) . It is known that immediate-early genes are expressed broadly in many tissues, and have extremely potent and fast signaling-induced responses, making them likely to be expressed highly in many contexts (34, 35) . Furthermore, our work has revealed that SynIEGs display homogeneous transcriptional responses after growth factor stimulation, even after random insertion throughout the genome using the PiggyBAC transposase (Figure 2D-E, Figure S2 ). This corroborates recent work in which local chromatin structure was seen not to affect transcription of individual genes (e.g. actin) (36) , and where gene expression was largely insensitive to some large-scale genome rearrangements (37) . All of this suggests that SynIEGs might indeed serve as a predictable platform for mammalian signaling-induced response regulation, but future studies will need to look carefully at other classes of genes before such engineering efforts are applied more broadly. As the field of synthetic biology gets closer to medical applications, especially in the burgeoning field of immunotherapy, cells will need to be engineered to interpret increasingly complex extracellular information (33) . SynIEGs implementing multi-step regulatory relationships could provide a valuable tool for achieving this goal.
Methods
Plasmid Construction
We cloned all of our constructs/synthetic gene circuits into previously published pHR lentiviral expression plasmid (2) or into Piggybac plasmid (38) . For large PCR products (>7500 bp), GXL polymerase was used, followed by overnight DPN1 digestion while for smaller PCR products, HiFi polymerase from Clontech was utilized. Sequences for pFOS, fos 5' UTR, fos 3' UTR, btg2 5' UTR, btg2 3' UTR, tubulin 3' UTR (can be found in supplementary sequences) were obtained via PCR from genomic DNA obtained from NIH 3T3 cells made using Epicentre's QuickExtract.
Sequences for BFP, YFP, MS2 loops and OptoSOS were obtained from plasmids published previously (14, 39, 40) . Destabilized GFP (dGFP) was obtained as a generous gift from the Reya lab (Addgene: 14715). Fra1 degron was based of FIRE reporter (20) , which was encoded within an IDT gBlock (sequence can be found in supplementary sequences). PCR products were then run on an agarose gel, purified using Takara Bio's Nucleospin gel purification kit. Final plasmids were constructed using Takara Bio's Infusion reagent, amplified in Stellar chemically competent E. coli and DNA was extracted using Qiagen miniprep kit.
Construction of a microRNA expression plasmid was made based off of lentiCRISPR v2 plasmid (41) in which the U6 promoter is followed by AgeI and EcoRI restriction enzyme cut sites which results in a 7125 bp and 1875 bp band on a agarose gel. The larger piece was excised and purified. miR21 sequence (agttgtagtcagactattcgat) and miR21 inhibitor sequence (tcaacatcagtctgataagcta) were encoded in duplexed primers with CCGG 5' overhang for the top strand and AATT 5' overhang for the bottom strand. T4 ligase was then used to ligate the microRNA sequences into backbone of the plasmid. The resulting plasmid was transformed into Stellar chemically competent E. coli and DNA was extracted using Qiagen miniprep kit.
All plasmid verification was done by restriction enzyme digestion and Sanger sequencing by submitting through Genewiz. All plasmids used in this study can be found in Table S1 .
PiggyBac Integration
NIH 3T3s to be integrated were plated 24 hours prior to transfection. 2.08 μ g of the plasmid to be integrated along with 0.41μg of the piggybac helper plasmid were co-transfected into the cells using Liptofectamine LTX with Plus reagent. Cells were selected using FACS for YFP expression after waiting at least 3 days post-transfection. SynIEGs from figures 2 and 3 were integrated into the "Chassis" clonal line described in (14) . Briefly, the Chassis clonal line is a NIH 3T3 cell line with BFP-Erk, MCP-mCherry, and H2B-iRFP. The fos-dGFP-btg2 synIEG was integrated into wild-type NIH 3T3s. Cells then underwent single cell sorting to isolate clonal cell lines bearing the various synIEG variants.
Lentivirus production
HEK 293Ts were plated in a 6 well plate at ~40% confluency at least 12 hours before transfection. The cells were then co-transfected with 1.5 ug of the pHR vector of interest along to be infected were plated at 40% confluency in a 6 well plate at least 12 hours before infection and then 200-500 ul of viral media was added the cells. 24 hours post transduction virus containing media was replaced with fresh media. Cells were then incubated for at least another 24 hours before sorting using FACS Aria or being placed on the microscope for experiments.
Cell line maintenance and preparation for imaging
NIH 3T3s were grown in DMEM plus 10% FBS in Thermo Fisher Nunc Cell Culture Tissue Flasks with filter caps at 37C and 5% CO 2 . Cells to be imaged were plated into InVitro Scientific's 96 well, black-walled, 0.17mm high performance glass bottom plates. 10μg/ml of fibronectin diluted in PBS was placed on the wells, washed off and then cells were plated in DMEM with 10% FBS at least 12 hrs prior to imaging. Between 4 and 6 hours prior to imaging, cells were placed in serum-free media (DMEM with 0.00476mg/mL HEPES). 50μL of mineral oil was pipetted onto the wells right before placing onto the scope to prevent media from evaporating.
Imaging and optogenetic stimulation hardware
Cells were maintained at 37°C with 5% CO 2 for the duration of an imaging experiment.
Confocal microscopy was performed on a Nikon Eclipse Ti microscope with a Prior linear motorized stage, a Yokogawa CSU-X1 spinning disk, an Agilent laser line module containing 405, 488, 561 and 650 nm lasers, 60x oil emersion objective and an iXon DU897 EMCCD camera.
For optogenetic microscope experiments, blue light from the XLED1 system was delivered through a Polygon400 digital micromirror device (DMD; Mightex Systems) to control the temporal dynamics of light inputs. We applied specific temporal patterns to an image by drawing ROIs within the Nikon Elements software package and using custom macros to turn on and off the light. To attenuate 450 nm light, we dithered the DMD mirrors to apply light 50% of the time, and set our 450 nm LED to 50% of its maximum intensity.
Drug Treatments
Drug additions were done with a 200 μ L gel loading pipette directly onto cells while they were on the microscope. Drugs were pre-diluted to a 1:10 stock concentration additions. Final concentrations for drugs were: cycloheximide (100 μ g/ml), doxorubicin (860nM), FBS (10% by volume for all experiments except for the AND-gate experiments which was done at 1% by volume).
Transcriptional Burst Analysis
Bursting MCP foci were imaged and quantified using a protocol adapted from (14) . Briefly, 7 zstack slices spanning 4.5 μ m (0.8μm between z-slices) which was centered on the middle of the nucleus. This z-stack was max projected to allow all of the bursts to be visualized on a single plane. Positional information was tracked using the measure tool in Fiji. MATLAB code was used to take in the positional information, fit a 2-dimensional Gaussian to the identified region and finally calculated the integrated area under the fitted Gaussian as the burst intensity. This code can be found in supplementary MATLAB file.
Microscopy Data Analysis
ND2 files from Nikon Elements software were imported into ImageJ. The measure tool was used to quantify mean intensity of the nuclei of cells of interest. These files were saved and then imported into R to do statistical analysis and graphing. Area-under-the-curve analysis was done by first averaging the first two timepoints to set the baseline. The area was then calculated by using the following formula:
The code for this analysis can be found in Supplementary code.
Statistical Analysis
Data figure legends include whether data is represented as mean ± S.E.M, mean + S.D or mean ± S.D as well as sample size. For AND gate experiments, the one-sided Student's t test was applied between serum and the combination of serum and doxorubicin. One-sided student's t test was
